Grigorescu V, Petrescu M, Popescu C
Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol. 1979 Oct-Dec;28(4):247-53.
An analysis was made, 12 months after strictly supervised treatment which included rifampicin and/or etambutol, of 83 cases of relapses of pulmonary tuberculosis. Therapeutic aspects were studied, as well as problems in relation to the possibility to continue work, as well as temporary invalidity. The therapeutic curing of the relapses was achieved in 74 patients (89,15 percent), while 9 remained with a positive bK in the sputum. The recovered subjects continued their activity without any changes in the working place, and retirement was accepted for active tuberculosis in 12,5 percent of the patients, while retirement for posttuberculous syndrome in another 7,14 percent of the patients. Males were predominant (81,81 percent of the total), mostly aged between 30 and 49 years, originating from rural environments.
在严格监督下进行包括利福平或乙胺丁醇在内的治疗12个月后，对83例肺结核复发病例进行了分析。研究了治疗方面的情况，以及与继续工作的可能性和暂时丧失工作能力相关的问题。74例患者（89.15%）的复发得到了治疗治愈，而9例患者痰液中的结核菌仍呈阳性。康复的患者继续工作，工作地点没有任何变化，12.5%的患者因活动性肺结核而退休，另有7.14%的患者因结核后综合征而退休。男性占主导（占总数的81.81%），大多年龄在30至49岁之间，来自农村地区。
